← FDA ENFORCEMENT
F-1321-2024Class I

Danisco USA Inc.

Recalling firm
Danisco USA Inc.
Product type
Food / supplement / cosmetic
Status
Terminated
Report date
2024-06-12
Distribution
US: AZ, CA, CO, FL, IA, ID, IL, IN, KS, KY, MI, MN, MO, NE, NJ, NY, OH, OK, PA, TN, TX, UT, VA, WI; Canada, and Mexico
Firm state
KS
Product quantity
61871.04 kg
Initiated by
Voluntary: Firm initiated
SPEQ quality domain
Environmental Monitoring
Reason for recall

Potential Salmonella Contamination

Product description

Grindsted TH GSD 2272 Stabilizer and Emulsifier System, bulk tote

Code / lot info

Lot numbers: 1204589332; 1204589333; 1204589334; 1204589335; 1204589336; 1204589337; 1204589338; 1204589339; 1204589340; 1204589341; 1204589342; 1204589343; 1204589344; 1204589345; 1204589346; 1204589347; 1204589348; 1204589349; 1204589350; 1204589351; 1204589352; 1204589353; 1204598302; 1204598303; 1204598304; 1204598305; 1204598306; 1204598307; 1204598308; 1204598309; 1204598310; 1204598306; 1204598311; 1204598312; 1204598313; 1204598314; 1204598315; 1204598316; 1204598317; 1204598319; 1204598320; 1204598321; 1204598322; 1204598323; 1204598324; 1204598307; 1204598310; 1204598321; 1204609238; 1204609239; 1204609240; 1204609241; 1204609242; 1204609243; 1204609244; 1204609245; 1204609246; 1204609247; 1204609248; 1204609249; 1204609250; 1204609251; 1204609252; 1204609253; 1204609254; 1204609255; 1204609256; 1204609257; 1204609258; 1204609259; 1204612440; 1204612441; 1204612442; 1204612443; 1204612444; 1204612445; 1204612446; 1204612447; 1204612448; 1204612449; 1204612450; 1204612451; 1204612452; 1204612453; 1204612454; 1204612455; 1204612456; 1204612457; 1204612458; 1204612459; 1204612460; 1204612461

Other recalls SPEQ maps to Environmental Monitoring
2026-07-22Class IArgon Medical Devices, Inc2026-07-22Class IIOlympus Corporation of the Americas2026-07-22Class IIChiesi USA, Inc.2026-07-22Class IICareFusion 213, LLC
See all Environmental Monitoring recalls →

Data: U.S. FDA openFDA enforcement API. Recall details are as reported by the FDA. The quality-domain mapping and severity are a SPEQ editorial interpretation of the recall reason, not an official FDA classification.